Evidence map›Paper›PMID 40072740›Full record

ArticleObesity surgery2025

Alcohol and Other Substance Screening in Bariatric Surgery Candidates: Utility of Self-Report and Toxicology Tests, Including Ethyl-Glucoronide.

Silvia Cañizares, Laura Nuño, Pablo Barrio, Mireia Forner-Puntonet, Carolina Gavotti, Miquel Monràs, Patricia Gavín, Ricard Navinés, Lilliam Flores, Maite Barrios and 5 more

Abstract read
In one paragraph

Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Silvia CañizaresSection of Clinical Health Psychology, Department of Psychiatry and Psychology, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Roselló 140, 08036, Barcelona, Spain. scanizar@clinic.cat.ORCID 0000-0003-3730-8327
Laura NuñoAddiction Unit, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.
Pablo BarrioAddiction Unit, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.
Mireia Forner-PuntonetSant Pau Mental Health Group, Department of Psychiatry, Hospital de La Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR Sant Pau), C/Sant Quintí, 89, 08025, Barcelona, Spain.
Carolina GavottiAddiction Unit, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.
Miquel MonràsAddiction Unit, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.
Patricia GavínSection of Clinical Health Psychology, Department of Psychiatry and Psychology, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Roselló 140, 08036, Barcelona, Spain.
Ricard NavinésDepartment of Psychiatry and Psychology, Clinical Institute of Neurosciences (ICN, Hospital Clinic of Barcelona, C/Roselló 140, 08036, Barcelona, Spain.
Lilliam FloresObesity Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, C/Villarroel, 170 08036, Barcelona, Spain.
Maite BarriosDepartment of Methodology of Sciences of the Behaviour, University of Barcelona, Edifici Ponent, Passeig de La Vall d'Hebron, 171, 08035, Barcelona, Spain.
Alba AndreuObesity Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, C/Villarroel, 170 08036, Barcelona, Spain.
Judit MoleroObesity Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, C/Villarroel, 170 08036, Barcelona, Spain.
Amanda JimenezObesity Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, C/Villarroel, 170 08036, Barcelona, Spain.
Josep VidalObesity Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, C/Villarroel, 170 08036, Barcelona, Spain.
Anna LligoñaAddiction Unit, Clinical Institute of Neurosciences (ICN), Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following bariatric surgery (BS) patients have an increased risk of alcohol misuse. PURPOSE: This 1-year cross-sectional study in potential BS candidates had several objectives: (a) assess the prevalence of risky drinking, alcohol use disorder (AUD), and other substance use/disorder; (b) compare the prevalence of these behaviors to that of the general Spanish population; (c) determine the proportion of patients with positive results in toxicology tests; and (d) study the predictive factors of risky drinking.

settingtertiary university hospital. MATERIALS AND

methodsAlcohol and other substance use were evaluated with the AUDIT-C and ASSIST questionnaires. Urine tests analyzed several markers (ethyl-glucoronide [EtG] ≥ 500 ng/ml, amphetamine, benzodiazepine, cannabinoid, cocaine, and opioid). The Mini-International-Neuropsychiatric-Interview (5.0.0) was employed to assess psychiatric diagnoses.

resultsAmong 308 candidates for BS, 196 were accepted to participate (69% women; mean age 46.7 ± 10.9 years; mean body mass index 45.6 ± 5.9). AUDIT-C and ASSIST identified 7% and 5% of risky drinkers, respectively. Men were more frequently risky drinkers compared to women (18% vs. 2%) and compared to the general population (18% vs. 8%). Six percent of individuals had AUD, being men the most affected, and 2% met criteria for other substance disorder. Fifteen percent of the sample presented risky tobacco use. Cannabis was self-reported only by males (3%). EtG ≥ 500 ng/ml was present in 15% of the sample, being a risk factor for risky drinking together with the male sex.

conclusionIdentification of candidates at risk for risky drinking can help to prevent any alcohol misuse after BS. The combination of subjective and objective measures improves the validity of the assessment of substance use.

Indexed as

Alcohol DrinkingAlcoholismBariatric SurgeryGlucuronatesObesity, MorbidSubstance Abuse DetectionSubstance-Related DisordersAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceSelf ReportSpainGlucuronatesAlcoholASSISTAUDIT-CBariatric surgeryDrugsEthyl-glucuronideObesityRisky drinkingToxicology

Identifiers

PMID40072740
PMCPMC11976782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.